# Pharmacodynamics Assessment Study After Single Subcutaneous Dose Of SAR113244 Versus Placebo In Lupus Male And Female Patients

> **NCT02331810** · PHASE1 · WITHDRAWN · sponsor: **Sanofi**

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** SAR113244
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02331810
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-04
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2016-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02331810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02331810, "Pharmacodynamics Assessment Study After Single Subcutaneous Dose Of SAR113244 Versus Placebo In Lupus Male And Female Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02331810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*